The Half-Billion-Dollar Secret To Doubling Your Returns In The Next 99 Days And, That's Just Your First Step Toward Gains That, In Less Than A Year, Could Find You Sitting On Returns So Significant That Some Might Call Them Obscene This Is Your Rare Opportunity To Own A Piece Of A Company That's Not Only Making Medical History - But Is Ideally Poised To Deliver You Potentially Life-Altering Profits… So, Forget About Pipe-Dream Drugs And Someday FDA Approvals… THIS COMPANY'S BREAKTHROUGH DEVICE DESTROYS CANCER TUMORS NOW… And That Includes Stubborn Prostate Cancers and Lung Cancers Dear Reader, So, it wasn't a day at the beach. But, the radical new cancer treatment - the one that destroyed a young Texas woman's brain tumor - wasn't anything like the brutal cancer treatments she was used to, thanks to a fantastic new device made by one small California company. It's because of this new cancer tumor destroyer - the one that doctors believe saved Faith O'Reilly's life - that this small company has piled up more than a half a billion dollars in backorders as a result of this prayer-answering device. Now, suddenly, stories like Faith O'Reilly's are being told across the globe every day. You see, Faith was counting down the days of her death sentence. Blinded and dying from a malignant brain tumor, she had endured two years of brutal chemotherapy to no avail. Faith had accepted the fact that each day she spent with her five-year-old son, Bobby, was a gift from God. A True Cancer Blaster But Faith lives in amazing times… when, in the nick of time, the arc from a breathtaking medical breakthrough can reach from Silicon Valley to Texas.   You see, Faith's doctors were some of the very first to put their faith in a new machine… one that pinpoints a beam of radiation therapy on cancer cells with unprecedented accuracy. After suffering two years of failed treatments, Faith's tumor was destroyed in two sessions… that's right, Faith O'Reilly's tumor was totally eradicated with just two sessions with this breakthrough cancer therapy. She told the Christian publication, The Health List, that her doctors are convinced the radical new cancer treatment saved her life. What makes this device even more of a miracle as Faith said, "I did not have any hair loss as I did with conventional chemotherapy, and there was less recuperation time and fatigue." So, Yes - This Is As BIG As It Sounds A company has developed a machine that actually blasts cancer cells from the body. You walk into the hospital with a tumor - what was once a death sentence - and this machine lines up the tumor - then blasts it. No surgery. No hospital stays. No chemotherapy. Less brutal fatigue… No hair loss… Just a series of outpatient treatments. You go home healthy… CANCER FREE. No wonder doctors and hospitals are lining up to get hold of this device. Here's What Cancer Doctors Are Raving About Dr. Robert Lin, Neurological Surgeon at a major western medical center - "It has revolutionized our ability to treat cancer patients." Dr. Jeffrey Hagen, Thoracic Surgeon at USC University Hospital - "One of the most gratifying things to me… is that it has given me the opportunity to help patients that I didn't have anything to offer before." Dr. Douglas Allen, associate professor of radiation oncology at a major southwestern U.S. hospital, "We're tackling fights that were not possible to tackle before the advent of this technology. We are going after tumors we have not treated routinely, and instead of going to the operating room and the recovery room, this can be done as an outpatient procedure." Dr. Dawn Grossmann, Oncologist at a major Los Angeles Cancer Hospital - "I've seen patients who've literally gone coast to coast looking for answers on how to best treat their tumors and have been turned away by a number of centers. Being able offer a treatment that can change their lives is a very exciting and rewarding experience for us, and we see it every day." Dr. Stuart Avery, Surgeon at a Midwestern community Hospital - "radiosurgery is now not only open to intracranial tumors but to spine tumors and then to additional tumors in the body from lung to pancreas to liver to prostate." "That's just a miracle in itself… They are saying start a family… lead as normal a life as you can, so it's a great positive outlook." - Wendy Kelleher, Stanford Medical Center cancer patient. A 3,621% GAIN! Multiplying Your Initial Stake By 18 Could Be Just A Sweet Beginning For You – Look Here Now To Find Out Why Just look at this… a 3,621% gain – or nearly 37 times an initial investment – a legendary historical gain that most people missed out on because, back in January 2003 few had heard of a company called Intuitive Surgical.  This staggering return is one that could have turned $1,000 into $37,000… $5,000 into $185,00… a $10,000 stake into $370,000… and, of course, $30,000 in $1,110,000. Better still, this is not some sort of ancient history lesson. This legendary gain could have been closed out on Sept 4, 2007… the day after Labor Day. That’s when ISRG closed at $224.05. But, back on Jan. 6, 2003, it was individual investors who bought ISRG shares at $6.02. How do we know it was farsighted individuals who bought at that price. Well, ISGR’s volume that January day was a mere 79,480… most of it looked like sell side orders, too. Today, the too-late crowd… those who missed out… push ISRG’s volume to around a million shares a day. What does Intuitive Surgical do? It makes robotic surgery machines – the kind used in urologic, cardiothoracic, gynecologic, and general surgeries. It doesn’t even have a cancer treatment! Yet, ISRG has delivered the most perceptive investors, those who recognized its breakthrough technology first, a stunning return that’s averaged out at 76.4% PER MONTH since January 2003. That’s why it’s vital that you fully explore the opportunity before you today. Because if a general surgery machine can generate this massive return… you can only imagine how well you’ll do with a company that makes a computer-driven device that actually destroys cancer tumors… And, how significantly a return of 3,361% – or 76.4% a month – could change your life. Why The Time Is Now For You Of course, you know how much of the world first reacted to this amazing device… especially the old guard who are in drug companys' pockets… you know, the drug companies that make old fashioned cancer treatment chemicals. When the breakthrough was first announced there was disbelief… They said, "No way such a device could work." After successful testing, there was skepticism… and, "Yes, but can it work on different tumors" And now that the device is being successfully used in more than 70 clinics and hospitals across the globe… the old drug companies are quaking because hospitals around the world are now demanding…  "How can I get my hands on one of these machines?" Sweet Music To Your Portfolio That's what investors love to hear… People clamoring to get their hands on a product that never before existed… A groundbreaking product that is only made and delivered by one company… That sounds to me like these other very recent big things such as Apple's iPod, which drove Apple's shares from $6.36 in April 2003 to $143.85 in August 2007… or Google's search engine, which drove its shares from $101 in August 2004 to $555 in August 2007… If you missed out on those, this opportunity could make you feel better about it… In fact, it's better than that… it's your rare opportunity to own what could be one of the most important companies of our time. Forget about the lives it could save - and the suffering it could end once and for all. Then, think about you and your family. Because, needless to say, this is a company that could potentially make you rich. I'm talking, depending on your stake, tens of thousands, hundreds thousands… even millions rich. Wall Street Blinked… Now You Could Bank A Fortune On The Street's Misstep Oh, what a screw up. The company you're about to meet is no big secret on Wall Street… after all, it came public on the NASDAQ, via an IPO, just a few months ago… so it's not flying under the radar, per se. But, the starched collars on the Street suffered a massive brain cramp when they looked at this small, fast-growing company… though some very smart fund managers loaded up, big time, as you'll see. Still, some of Wall Street's sharpest minds totally whiffed on this one. They didn't get this story, or the power of this new device. So you have a huge edge here.  That's because they were so busy focusing on Apple, Google and PetroChina that they totally misread the company's breakthrough cancer killing technology. These top-flight analysts must have mistakenly thought it was just another take on a standard radioisotope therapy tool in an already crowded market… a market that until now, generally used radiation to inaccurately treat tumors, or to prevent cancer from spreading… not to eradicate cancer. Dumb! Dumb! Dumb! And Dumber! But now, Wall Street's foul-ups leave the door ajar for individuals like you… individuals looking for A BIG SCORE… Like when analysts thought Google was over-priced at $108… or at $200… then went charging up to $250. They left a lot of money on the table… because Google is at $505, as I write… all because they failed to take the time to accomplish one critical task… understand the company and the market.  But, Dumb and Dumber Eventually Get Smart Wall Street's failure to understand the cancer blasting power of this company's new product… to assess the virtually limitless global market…  is why this stock is so inexpensive today, instead of at $30 or $40… This huge miscalculation is one that you could be able to immediately exploit for scalable profits that - depending on your initial stake - could run from tens of thousands, hundreds of thousands… even millions. The opportunity is just that fat. Because, as you'll see, this small company just put up some impressive quarterly numbers… on top of that, it's projecting it will double revenues next year… and get this… it still has no debt. This is why you need to take a minute and take a closer look at this brilliant young outfit. Like Jim Brown In A Wide Open Field… Or Ted Williams With A Belt-High Fast Ball… You Just Need To Let 'Er Rip With This One CASE STUDY #1 – Lung Cancer “The system delivered a painless, complication-free treatment to this patient with a recurrent tumor who received previous conventional external beam radiotherapy. This treatment achieved local control with no radiographic evidence of disease nearly two years after treatment.” You see, Wall Street is totally wrong. The new tumor blaster doesn't just compete with existing radiation therapies - it competes with the surgeon's scalpel! Let me explain…  Because of this new device's incredible documented success, especially with common cancers - such as those in the prostate, breasts and lungs - most cancer patients who are treated with this device no longer have to undergo surgery to remove their tumors. For many, it's the first real hope they've had in years. And, it's why hospitals across the globe are so hungry for this breakthrough device that the company has a half-billion dollars (and growing) in backorder. After all… Think of the benefits to the patient - This treatment is non-invasive and less painful than traditional treatment methods.  Patients undergoing treatment with it can get up and go home at the end of their session. Compare that to surgery where patients must mend in the hospital quite uncomfortably for days… and remain sore and achy for weeks afterwards. Think of the benefits to the hospital - To be quite blunt… this device could be a huge profit center for hospitals, (another reason why the company has more than half a billion dollars in backorders).  That's because there's a ton of overhead associated with surgery… not to mention with the patient's recovery time spent in the hospital. So, although this treatment costs less than surgery, the margins are higher and thus more profitable for the hospital. Think of the benefits to the health insurer - The cost of this treatment is a fraction of what surgery costs.  Plus, staying out of the hospital could reduce the likelihood of complications and ancillary infections, which can lengthen the amount of time in the hospital and increase costs. Think of the potential benefits to your bottom line… The patients win… the hospitals win…  and the insurance companies win… why shouldn't you win, too?  Because, now, you have an opportunity to score in a big way by getting into these shares before Wall Street figures out it's made a mistake… and I believe that it will catch up… but you'll be poised… ready for what could be a serious and inevitable run on this small company's shares. And, that's just what the doctor ordered as a cure for these curious financial times… the real opportunity to build a small fortune. Your Ground-Floor Market Opportunity What's at stake for you here is a simple proposition. This new device is not to be confused with standard radiation therapy, which is a common hit and miss treatment for cancer. No, it is designed to replace conventional surgery. You know, the kind of invasive assault on the body where a cancer patient goes under the knife and the surgeon cuts out as much of a tumor as can safely be removed.  After that, patients heal from surgery and then they likely undergo radiation therapy and/or chemotherapy in order to get what the doctors missed. But, A Radical New Approach Has Amazing Successes But, this new technology - the one developed by just one small company - means that patients may no longer have to be cut open… “I'm a techno nut to begin with. So when I read your analysis on xxxxxxx I bought it based on the strong case you made for the company's technology and sound management. I'm up 51.6%. Thank you very much!!!” – Clovis B., Little Canada, MN Now, because of this new device, they can drop by an outpatient center - say after a round of golf, or a morning of cards - and relax more comfortably while an intensely focused radiation beam ablates, or evaporates, the tumor… and kills the cancer cells without harming healthy tissue. And, I am with you… in that you'd think in the modern world of technological miracles that someone would have come up with this idea before now. Well, a lot of companies have been trying… but only one company solved the essential problem with this type of treatment… and it proved the solution time and time again… now hospitals around the globe want this new device. The problem this company solved has to do with patient movement… as in every breath you take causes slight movements throughout your entire body… so, as you might as well imagine, even a two millimeter deviation with a blast of radiation is something you'd want to avoid. We'll get to the solution in a second, but it will make more sense to you if you know a bit more about this hot young company's history of medical breakthroughs. Robo-Doc To The Rescue This company's device was originally only used on brain tumors. That's because, with a brain tumor it was medically possible to get a metal frame screwed into a patient's skull in order to prevent movement. The metal frames already existed for other types of invasive brain surgery. So that was a good start, because the last thing you want is a heavy dose of radiation blasting healthy brain tissue because the patient squirmed or twitched… but, the frame method has it drawbacks… You see… a lot can happen in the hour or so needed during radiosurgery… the biggest drawback was - incredibly - that as a result of being radiated, the tumor could move. Weird, huh? But, true. Because the company is populated with computer geniuses - and not just doctors - it was able to develop a radical new way of super-accurately delivering a dose of radiation directly to a tumor… whether it or the patient moved.  In fact, because of this new technique - and the employed image guidance robotics technology - the company eliminated the need for the metal frames that screwed into patients' skulls. A New Way To Skin A CAT Its new device used the basic tenets of a CAT scan - CAT, by the way, stands for Computerized Axial Tomography - to take hundreds of pictures per second of the tumor and adjust the radiation beams based on the movement not only of the patient but the tumor itself!  CASE STUDY #2 – Breast Cancer This patient reported no adverse side effects from the treatment delivery based on monthly follow-up exams. A CT scan acquired 3 months after treatment (December 2002) revealed decreased extent of the nasopharyngeal mass. Additional CT scans at 6 and 18 months and a PET scan at 21 months showed no evidence of disease. This treatment achieved local control with no radiographic evidence of disease nearly two years after treatment. Then, driven by the images, a surgical robot keeps track of these movements and adjusts the radiation to continue treating the tumor while avoiding healthy tissue.  Because of the intelligence built into the system, it can aggressively attack more of the tumor while hurting healthy tissue less than even the most skilled surgeon. And, affecting the healthy tissue is a critical concern for physicians.  With the traditional head-frame method of radiation treatment, patients had to be treated with all of the necessary radiation in a single dose because it is too onerous and uncomfortable to attach the frame more than once… remember, it was screwed into the skull… ugh! A Breakthrough Treatment Grows Out Of Proven Results But, with the company's radical new method - the breakthrough - cancer patients can now receive a precise dose of radiation that's been juiced up with microwaves to accelerate the tumor blasting electrons. And, miraculously, this intense cancer-ablating beam is delivered on target, typically with sub-millimeter accuracy. As you saw earlier, this is the device that doctors believe saved Faith O'Reilly's life. And, while the following may sound bitterly cold to you… there are probably only 84,000 brain cancer patients in the U.S. that could benefit from this radical new treatment… maybe a half million more worldwide… So, while the new device may be a Godsend to them… brain cancer is not much of a market… the kind that could drive this company's stock to $35 in the coming months… then to $100 or higher over the next year or so. How High Do You Think A Brand New Prostate Cancer Killer Will Fly? So why, then, am I so high on this small company? So high on it, in fact that I have spent months researching the company in order to write an in-depth Research Report on it… a report you'll want to access immediately, today. Well, as you'd likely guessed, with the help of the medical community - courageous doctors who immediately understood this device's ultimate implications - this precise cancer-killing instrument is now being used on cancers of the spine, lung, pancreas, prostate, liver and breast - expanding the market size nine-fold.  In fact, 30,000 patients have already been treated with it… and demand for the device is flowing in from all corners of the world. And, that's despite the fact that the device is not cheap… each individual unit sells for about $4 million… on top of that, the company is the only one that services the unit… so the maintenance contracts are piling up too. This Could Be Your Best Play Of The Year - Bar None "[Xcelerated Profits] is outstanding, informative and educational. I have made substantial gains. I can tell you there is no hype in this newsletter and in what I am saying.” – Sung K., West Chester, OH So, the math is relatively simple to do… tons of orders in the coming months alone… along with contracts to maintain the units… all should add up to unprecedented soon-to-be-realized revenues… and that could only be the beginning. In fact, I want to break down the numbers for you in a bit more detail… also show you how ethical this company is in the manner by which it reports its sales… But first, perhaps it's time you learned a bit more about me and about the stellar team that I am a part of. Then, you'll get right back to the numbers behind the one and only company that has a breakthrough device that's proven to blast cancer tumors to smithereens, today! One final thought here… the World Health Organization estimates that cancer rates could increase by 50% in the next 12 years alone! Xcelerated Profits Means Just What You'd Think   My name is Marc Lichtenfeld. Chances are, you've read my work when I was a Senior Columnist at TheStreet.com or RealMoney.com - two incredibly famous financial news outlets that were founded by that Mad Money guy… Jim Cramer. If you Google me - which is kind of embarrassing to me because of all the hits you'll get - you'll see many articles and commentary within various sectors… mostly retail and biotech. An odd mix, yes, but one in which I became an expert at analyzing and finding winning companies with tons of revenues and ongoing businesses, as well as ones, such as biotechs, that sometimes are only a dream… a great idea with no revenues. Prior to my stint at TheStreet, I was a Senior Analyst at The Avalon Research Group… I also had a very successful run as the co-manager of Weiss Research's Real Wealth Portfolio. So, I've been around the block a couple times… and if you know the retail and biotech sectors, you know that unless you are an expert with great industry sources, those blocks can be more like minefields. But as you get to know me better, you'll find that the only things that explode on my watch are profits… time and time again… Your Immediate Access To Not Just One… But To A Whole Slew Of Potentially Life-Altering Returns CASE STUDY #3 - Cancer Tumor On The Spine The patient was seen for multiple follow-up evaluations after completing [treatment]. One week after therapy the patient was able to stop pain medication. Neck pain completely resolved after two weeks and walking improved considerably. MRI follow-up scan four weeks after therapy showed tumor shrinkage, with considerable reduction in the spinal cord compression. Three months after treatment she continued to be off pain medication and pain free. There were no adverse treatment effects during the follow-up period. One of the reasons I know so much about this unique opportunity before you today - the cancer tumor destroyer - is that I am the newest member of one of the most successful financial trading research firms in the country, for private individuals and investors only. How successful, you might ask? Well, our legal team confirmed that one of our firm's members… one I want you to gain immediate access to…  consistently booked better than 72% winning picks in the past six years using just one specific, ultra-safe, easy-to-understand strategy - time and time again. For individuals just like you - hungry for fast gains and the opportunity to put the pedal to the metal - this astute team of veteran experts has been able to consistently accelerate their gains. It's proven to significantly increase your money each year on steady, fast-moving recommendations. I say this all not to brag, but to alert you to one vital thought. Because of the way global cancer rates are expected to increase, the company you are reading about today, is perhaps the most profit-potent company our team has ever uncovered - and yet it's one of the safest opportunities I've ever come across… Though we have, as you'll see, a number of other low to mid triple-digit opportunities for you, the entire team is bouncing off the wall with excitement over this breakthrough cancer treatment company. This Is How You Could Roll To The 21st Century's Top Returns By the way, our team includes these veteran analysts: Lee Lowell - Commodity Specialist with 14 years experience, including six years as a floor trader and market maker on the New York Mercantile Exchange. He was one of a handful of experts who set the daily price for oil. James Stanton - Pattern Recognition Specialist with 27 years as a top trader and the recipient of Winner's Circle Magazine's highest award for his two-year audited return of 258%. Marc Lichtenfeld (me) - Senior Analyst - a former trader and writer for TheStreet.com whose contrarian approach has helped me beat the S&P 500 by 200%. And our leader, and founder, Karim Rahemtulla… a legendary Oxford Club Wealth Panel member… CNBC "Market Maven"… and a man who may have the greatest all-time trading record. We have come together to produce what you should discover to be the most powerful, and affordable trading research service available today. It's called the Xcelerated Profits Report. And for an exceedingly low rate… and I do mean exceedingly low… XPR is unlike anything you've likely seen before… especially when you compare the pennies-a-day subscription rate to the services XPR delivers you, each day, week, month and year. These are crucial and potentially profitable services that, as you'll see in a bit and experience when you subscribe… Immediately respond to the most pressing financial needs of investors in the current markets… Confidently guide our readers through market conditions, from the mundane days to the crazy days… Address potential concerns in a manner that respects what's at stake… Comes from seasoned authorities… mature traders who innately understand that big ideas are more than just marketing ploys… Now, you're going to get a good look at the whole ball of wax in just a second - the Xcelerated Profits Report track record and you'll hear from a slew of happy subscribers - but, I am sure you're now like the entire XPR team and are extremely excited about the opportunity that's before you today… so let's get back to it. The Sad Reality Of The "Western" Disease… And Why You Are Actually Investing In Hope Here are some brutal numbers. "I have been following your reco's since I joined… and I must say that I am extremely impressed with the results that I see…” – Hans K., Calgary, AB In the year 2000, the World Health Organization (WHO) reported that malignant tumors were responsible for 12% of the nearly 56 million deaths worldwide. WHO went on to report that in developed countries, the probability of being diagnosed with cancer is more than twice as high as in developing countries. In rich countries, some 50% of cancer patients die of this disease. The main reasons for the greater cancer burden of affluent societies include the earlier onset of the tobacco epidemic, the earlier exposure to occupational carcinogens and the Western nutrition and lifestyle. Now, here’s the biggie… WHO experts say that increasing wealth and industrialization will find many countries undergoing rapid lifestyle changes that will greatly increase their future disease burden. Once considered a Western disease, a WHO report highlights that more than 50% of the world’s cancer burden, in terms of both numbers of cases and deaths, already occurs in developing countries. “Cancer has emerged as a major public health problem in developing countries for the first time, matching its effect in industrialized nations. This is a global problem, and it’s growing,” says Paul Kleihues, MD, Director of IARC and co-editor of the World Cancer Report. One Small Company's Device Obliterates Tumors As a private person these numbers equate to lots of pain for lots of families. But, if you want to look at it as an investor - one who is responsible for their own family's well being - you'll find these numbers could be the backbone for one of the most outstanding opportunities ever. Here's why. "I subscribe to at least a half-dozen newsletters and have purchased more recommendations from Xcelerated Profits than any of the others, and the results have been more impressive. The diversification of your recommendations is something many of the other newsletters do not provide. Keep up the good work.” – Frank C., Maumee, OH You see, the tumor-blasting device you're reading about today has been found effective against cancers of the lung, prostate, breast and liver… along with brain tumors. And lung, prostate, breast and liver cancers are some of the world's most commonly found cancers. In fact, lung cancer is the most common cancer worldwide, accounting for 1.2 million new cases annually. It's followed by breast cancer with just over 1 million new cases each year; colorectal, 940,000; stomach, 870,000; liver cancer with more than 560,000 new cases each year; cervical, 470,000; esophageal, 410,000; head and neck, 390,000; bladder, 330,000; malignant non-Hodgkin lymphoma, 290,000; leukemia, 250,000; prostate and testicular, 250,000; pancreatic, 216,000; ovarian, 190,000; kidney, 190,000; endometrial, 188,000; nervous system, 175,000; melanoma, 133,000; thyroid, 123,000; pharynx, 65,000; and Hodgkin disease, 62,000 cases. The Numbers Are Truly In Your Favor And, check out the story these numbers really tell. You see, industrial nations with the highest overall cancer rates include: U.S., Italy, Australia, Germany, The Netherlands, Canada and France. Developing countries with the lowest cancer were in Northern Africa and Southern and Eastern Asia. (A complete list of cancer rates by countries can be found at http://www-dep.iarc.fr/). So, when you assess this opportunity, please don't lose sight of the fact that these numbers represent new cancers found each year. Or the fact that industrialized nations - the ones with the highest cancer rates - are just the nations with hospitals that can afford the $4 million cancer blasting device made by just one small company. That means, to be exceedingly blunt… the market for a new cancer "treatment" could be virtually unlimited. Especially if it is one that blasts tumors and keeps patients active and busy, instead of worn out by chemical treatments… You Could Immediately Tap Into A Potential $7.5 Billion Market So, for you, this is where the rubber meets the road, it's why you need to grab hold of this opportunity today… because these lifesaving devices are not cheap. "We are collecting dividends of 9% on shares of Madison/ Claymore Covered Call Fund, and Algonquin Power Fund. All solid, steady, stress-free returns to support our retirement. Given the modest subscription cost… it has provided the best return on investment of any of the newsletters to which we have subscribed - no small sample, over 30 years of investing.” – A. P., Burlington, ON They cost roughly $4 million apiece. So you know that any hospital that is planning on ordering one or two units has considered this purchase very carefully.  And, truth be told, that also means the sales cycle, from contract to installation, is fairly long… roughly eight to 18 months.  On the other hand, that enables the company to have a very clear picture of what its business should look like one to two years down the road. And, by the way, I mentioned to you that the company was very ethical. So you should be pleased with the fact the company doesn't recognize the revenue from a sale until a unit is installed. When a facility such as Georgetown University Hospital signs a contract to purchase a unit for $4 million, that $4 million becomes backlog until the unit is installed and the company recognizes the revenue. That means, with over $300 million in backlog from system sales, you can feel confident that revenue should pour in over the next 18 months, alone… And the better truth is, and you should love this, the company has nearly $300 million in additional revenue it's set to book based on the maintenance contracts it has to service the machines once they're installed. You Can Stay At Home With A Low-Risk Global Opportunity One of your best advantages with aligning yourself with the Xcelerated Profits Report team is that as veteran former traders we remain very much a part of the "floor trader fraternity." These are unusual resources you generally can't find in even the most expensive, top-dollar trading research services, let alone one as accessibly affordable as XPR. But, the upshot is, our global contacts allow us to go much deeper than a common SEC report… or news that's easily found on financial websites. It's why XPR readers were able to quickly bank 150.00% on Verizon, as "trading sentiment" pushed this stock over the top… 313.79% on Boston Properties Group after Alan Greenspan expressed concern over subprime lending trends…100.00% on the Dow Jones "tracking stock," as the market dropped over 500 points in one day… It also means that when a company such as the one that makes the tumor blasting device claims there's a worldwide market of approximately 7,500 cancer centers and roughly half of those in the United States… we put our resources to work and make sure that claim is true. And, of course that claim is true… but there's a big BUT… a significant number of those clinics and hospitals either don't treat cancers that the breakthrough device eradicates… or, today, they can't afford the $4 million price tag. A Potential Moneymaker On A Massive Scale Still, we believe that as many as 30% of the hospitals and clinics in the world that treat cancer might be able to afford at least one of these marvelous, potentially life-saving devices. "I have used the Madison Claymore for my Roth, my wife's and my daughter's retirement funds. The return has been exactly what I had hoped for. Enough capital gains to satisfy, but conservative enough to let me sleep at night. Thanks so much and keep them coming.” – John D., Falls Church, VA Why? Well don't lose sight of the fact that the majority of aggressive cancer treatment is found in the first world… as you've seen, in places such as the U.S., Germany, England, France and Russia. And that's all because of medicine's dirty little secret… you know what it is if you just think about your community and its local hospitals… Because the secret is… FOR PROFIT HOSPITALS MUST TURN A PROFIT… NONPROFIT HOSPITALS MUST TURN A PROFIT, TOO.